TherapeuticsMD, Inc.
TXMDNasdaqCIK 25743HealthcareFiscal year ends Dec 31
Reports and events: 392 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2021-09-1717:00 ET | 8-K | 3.01 Delisting notice | 0001564590-21-048250 |
| 2021-09-0706:50 ET | 8-K | 8.01 Other events | 0001564590-21-047142 |
| 2021-08-0916:35 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-21-042695 |
| 2021-08-0416:56 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001564590-21-040907 |
| 2021-08-0407:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-21-040490 |
| 2021-05-2817:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-21-177164 |
| 2021-05-0616:56 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001193125-21-153419 |
| 2021-05-0607:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-21-152445 |
| 2021-04-1417:14 ET | DEF 14A | Proxy statementPeriod 2021-05-27 | 0001193125-21-116458 |
| 2021-04-1206:55 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001387131-21-004324 |
| 2021-03-0419:48 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001387131-21-003140 |
| 2021-03-0207:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-21-003075 |
| 2021-02-1608:35 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001387131-21-002393 |
| 2021-01-1308:50 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-21-000535 |
| 2020-11-2716:35 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001387131-20-010302 |
| 2020-11-1321:18 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-20-291974 |
| 2020-11-0909:22 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001387131-20-009695 |
| 2020-11-0906:55 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-20-009685 |
| 2020-09-1406:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-20-008293 |
| 2020-08-0718:38 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0001387131-20-007144 |
| 2020-08-0606:56 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-20-007080 |
| 2020-06-2306:51 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-20-005881 |
| 2020-06-1816:21 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001387131-20-005767 |
| 2020-06-0106:52 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-20-005353 |
| 2020-05-1517:03 ET | 8-K | 1.02 Termination of a material agreement; 8.01 Other events | 0001387131-20-004921 |
| 2020-05-1307:07 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-20-004678 |
| 2020-05-0617:23 ET | 10-Q | Quarterly reportPeriod 2020-03-31 | 0001387131-20-004479 |
| 2020-05-0606:55 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-20-004451 |
| 2020-05-0417:01 ET | DEF 14A | Proxy statementPeriod 2020-06-18 | 0001387131-20-004409 |
| 2020-05-0117:10 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001387131-20-004356 |
| 2020-04-2921:48 ET | 10-K/A | Annual report, amendedPeriod 2019-12-31 | 0001387131-20-004224 |
| 2020-04-2217:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001387131-20-004062 |
| 2020-03-2616:06 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001387131-20-003271 |
| 2020-03-2407:53 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-20-003130 |
| 2020-03-0307:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-20-002411 |
| 2020-02-2416:18 ET | 10-K | Annual reportPeriod 2019-12-31 | 0001387131-20-002086 |
| 2020-02-2006:57 ET | 8-K | 2.02 Results of operations; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-20-001953 |
| 2020-01-1406:55 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-20-000236 |
| 2019-12-3007:02 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-19-009918 |
| 2019-12-1817:27 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-19-009657 |
| 2019-11-1906:46 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-19-008853 |
| 2019-11-0816:17 ET | 10-Q | Quarterly reportPeriod 2019-09-30 | 0001387131-19-008469 |
| 2019-11-0616:08 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-19-008376 |
| 2019-10-2908:52 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-19-277097 |
| 2019-10-2317:25 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-19-272703 |
| 2019-10-1507:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-19-007619 |
| 2019-10-0107:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-19-007303 |
| 2019-09-2506:31 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-19-007118 |
| 2019-09-1606:46 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-19-006944 |
| 2019-08-0915:00 ET | 10-Q | Quarterly reportPeriod 2019-06-30 | 0001387131-19-005935 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 19:24 ET. Listed shows no prices and gives no investment advice.